(August 12, 2016, 1:31 PM EDT) -- WASHINGTON, D.C. — Arguments will be heard Sept. 29 on the centralization of federal lawsuits in which breast cancer patients allege that the chemotherapy drug Taxotere causes permanent hair loss, according to an Aug. 11 hearing order of the Judicial Panel on Multidistrict Litigation (JPMDL) (In Re: Taxotere [Docetaxel] Products Liability Litigation, MDL Docket No. 2740, JPMDL)....